Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TALWIN NX

NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE

Standard Dose
EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview TALWIN NX is listed in Drugs@FDA under application 018733 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-02-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview TALWIN NX is listed in Drugs@FDA under application 018733 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 0.5MG BASE;EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-02-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.
TALWIN NX (NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline